A carregar...
Weekly Carboplatin and Paclitaxel for Ovarian Cancer: The “Finer Points”
First‐line ovarian cancer platinum doublet is paclitaxel‐carboplatin. Superiority of weekly paclitaxel schedules has not been confirmed; however, a novel schedule with both drugs given weekly (days 1, 8, 15) followed by a 2‐week break may be advantageous to some.
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7794168/ https://ncbi.nlm.nih.gov/pubmed/33098242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13572 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|